Form 4: SI-BONE Executive Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Michael A. Pisetsky, SVP of Operations & Administration and Chief Legal Officer at SI-BONE, Inc., reported the sale of company shares to cover tax withholding obligations upon the vesting of restricted stock units.
Summary
- Michael A. Pisetsky, a key executive at SI-BONE, Inc., has reported the sale of company common stock.
- The transactions occurred on April 1st and April 2nd, 2026.
- These sales were conducted to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- The sales were executed as 'sell to cover' transactions, meaning they were not discretionary investment decisions but rather a mechanism to satisfy tax liabilities.
- Pisetsky sold a total of 3,134 shares across multiple transactions at weighted average prices of $12.9525 and $12.8634.
- Following these transactions, Pisetsky beneficially owns 282,840 shares of SI-BONE common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While it involves stock sales, the clear explanation that these are mandatory 'sell to cover' transactions for tax withholding mitigates negative sentiment.
Positives
- The executive's stock sales were solely to cover mandatory tax withholding, indicating a commitment to fulfilling financial obligations related to equity compensation.
- The 'sell to cover' mechanism is a standard and accepted practice for managing tax liabilities associated with equity awards.
- The executive continues to hold a significant number of shares (282,840) after the transactions, suggesting ongoing confidence in the company.
Negatives
- The sale of company stock by an executive, even for tax purposes, can sometimes be perceived negatively by the market if not clearly explained.
- The weighted average sale prices indicate a slight downward trend in the price at which shares were sold over the two days.
Risks
- While these specific sales are for tax withholding, future sales by executives could be interpreted as a lack of confidence if not accompanied by clear explanations.
- The company's stock price performance could be influenced by broader market conditions or company-specific news, impacting the value of executive holdings.
Future Outlook
This filing does not contain forward-looking statements or guidance. It solely reports on past transactions.
Management Comments
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- The sale satisfies the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.
- The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine for executives receiving equity compensation. The 'sell to cover' strategy is a common method to manage the tax implications of RSUs, particularly in growth-oriented technology companies like SI-BONE, where equity awards are a significant part of compensation. The volume of shares sold is relatively small compared to the executive's total holdings.
Stakeholder Impact
- Shareholders: The sale is for tax purposes and does not represent a sale of shares based on the executive's view of the company's future prospects, thus minimizing negative impact.
- Employees: This filing is specific to executive compensation and tax management and has no direct impact on other employees.
- Management: Demonstrates adherence to compensation plan terms and tax regulations.
Next Steps
- The reporting person will continue to hold their remaining shares.
- Future vesting of RSUs may lead to similar 'sell to cover' transactions if tax obligations arise.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Earliest transaction date reported for stock sales. |
| 04/01/2026 | Transaction date for the sale of 1,799 shares at a weighted average price of $12.9525. |
| 04/02/2026 | Transaction date for the sale of 1,301 shares at a weighted average price of $12.8634. |
| 04/02/2026 | Transaction date for the sale of 34 shares at $12.61. |
| 04/03/2026 | Date of signature for the Form 4 filing. |
Keywords
SI-BONE, SIBN, Form 4, Stock Sale, Executive Compensation, Restricted Stock Units, Tax Withholding, Beneficial Ownership, SEC Filing, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.